Local Institution - 0219 — Minneapolis, Minnesota

Local Institution - 0219 is a clinical research site located in Minneapolis, Minnesota, United States 55455.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 0219 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed or Refractory Multiple Myeloma (RRMM).

Sponsors: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Minneapolis

Browse all research sites in Minnesota · View every site in Minneapolis

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0219?

Local Institution - 0219 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0219 conducted?

Local Institution - 0219 has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed or Refractory Multiple Myeloma (RRMM).

Is Local Institution - 0219 accredited by Crixeo Clinical Trials?

Local Institution - 0219 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0219?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.